Erratum (DOI:10.1016/j.annepidem.2006.01.009);Determinants of Progression to AIDS or Death After HIV Diagnosis, United States, 1996 to 2001

Annals of Epidemiology

Volumn 16, Issue 11, 2006, Pages 824-833

  Hall, H Irene ^a   McDavid, Kathleen ^a   Ling, Qiang ^a   Sloggett, Andrew ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Acquired Immunodeficiency Syndrome (AIDS); Human Immunodeficiency Virus (HIV); Survival

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; AMERICAN INDIAN; ARTICLE; CAUCASIAN; DEATH; DISEASE COURSE; DRUG ABUSE; ETHNIC DIFFERENCE; FEMALE; HEALTH SURVEY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; SEXUAL BEHAVIOR; SURVIVAL TIME; UNITED STATES;

EID: 33751238527     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2007.06.003     Document Type: Erratum

References (40)

1. US Department of Health and Human Services. Healthy People 2010 (Conference Edition, in two volumes) (2000), US Government Printing Office, Washington, DC
2. Lee L.M., Karon J.M., Selik R., Neal J.J., and Fleming P. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. JAMA 285 (2001) 1308-1315
3. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 15 (2003) 1-46. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2003report/ default.htm . Accessed May 24, 2006
4. CASCADE Collaboration. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 362 (2003) 1267-1274
5. Estève J., Benhamou E., and Raymond L. Statistical Methods in Cancer Research, vol IV. Descriptive Epidemiology. IARC Scientific Publications No. 128 (1994), International Agency for Research on Cancer, Lyon
6. Berkson J., and Gage R.P. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clinic 25 (1950) 270-286
7. Ederer F., Axtell L.M., and Cutler S.J. The relative survival: A statistical methodology. Natl Cancer Inst Monogr 6 (1961) 101-121
8. StataCorp. STATA Statistical Software. Survival analysis and epidemiologic tables. Release 7.0 (2000), StataCorp, College Station, TX
9. Arias E., Anderson R.N., Hsiang-Ching K., Murphy S.L., and Kochanek K.D. Deaths: Final Data for 2001. National Vital Statistics Reports; vol 52, no 3 (2003), National Center for Health Statistics, Hyattsville, MD. http://www.cdc.gov/nchs/data/nvsr/nvsr52/nvsr52_03.pdf . Accessed April 24, 2004
10. National Center for Health Statistics. Bridged-Race Intercensal Estimates of the July 1, 1990-July 1, 1999, US Resident Population by County, Single-Year of Age, Sex, Race, and Hispanic Origin, Prepared by the US Census Bureau with support from the National Cancer Institute. Available at: http://www.cdc.gov/nchs/about/major/dvs/popbridge/popbridge.htm . Accessed April 24, 2004.
11. National Center for Health Statistics. Estimates of the July 1, 2000-July 1, 2002, United States Resident Population From the Vintage 2002 Postcensal Series by Year, County, Age, Sex, Race, and Hispanic Origin, prepared under a collaborative arrangement with the US Census Bureau. Available at: http://www.cdc.gov/nchs/about/major/dvs/popbridge/popbridge.htm. Accessed August, 1, 2003.
12. Coleman M.P. Cancer Survival Trends in England and Wales, 1971-1995: Deprivation and NHS Region. Studies in Medical and Population Subjects, no. 61 (1999), Stationery Office, London 38-41
13. Ewbank D.C., Gomez de Leon J.C., and Stoto M.A. A reducible four-parameter system of model life tables. Popul Stud 37 (1983) 105-129
14. Egger M., May M., Chêne G., Phillips A.N., Ledergerber B., Dabis F., et al., for the ART Cohort Collaboration. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet 360 (2002) 119-129
15. Dickman P.W., Sloggett A., Hills M., and Hakulinen T. Regression models for relative survival. Stat Med 23 (2004) 51-64
16. Hakulinen T., and Tenkanen L. Regression analysis of relative survival rates. Appl Stat 36 (1987) 309-317
17. Estève J., Benhamou E., Croasdale M., and Raymond L. Relative survival and the estimation of net survival: Elements for further discussion. Stat Med 9 (1990) 529-538
18. Breslow N.E., and Day N.E. Statistical Methods in Cancer Research, vol II. The Design and Analysis of Cohort Studies. IARC Scientific Publications No. 82 (1987), International Agency for Research on Cancer, Lyon
19. Centers for Disease Control and Prevention. Diagnosis and reporting of HIV and AIDS in states with integrated HIV and AIDS surveillance-United States, January 1994-June 1997. MMWR Morb Mortal Wkly Rep 47 (1998) 309-314
20. Grambsch P.M., and Therneau T.M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515, 526
21. Amato D.A. A generalized Kaplan-Meier estimator for heterogeneous populations. Commun Stat A Theory Methods 17 (1988) 263-286
22. US Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, April 7, 2005. Available at: http://AIDSinfo.nih.gov. Accessed May 10, 2005.
23. Teshale E, Kamimoto L, Harris N, Li J, Wang H, McKenna M. Estimated Number of HIV-Infected Persons Eligible for and Receiving HIV Antiretroviral Therapy, 2003-United States. Presented at: 12th Conference on Retroviruses and Opportunistic Infections, Boston, MA; February 22-25, 2005.
24. Palacio H., Kahn J.G., Richards T.A., and Morin S.F. Effect of race and/or ethnicity on use of antiretrovirals and prophylaxis for opportunistic infection: A review of the literature. Public Health Rep 117 (2002) 233-251
25. Wutoh A.K., Elekwachi O., Clarke-Tasker V., Daftary M., Powell N.J., and Campusano G. Assessment and predictors of antiretroviral adherence in older HIV-infected patients. J AIDS 33 Suppl (2003) S106-S114
26. Shapiro M.F., Morton S.C., McCaffrey D.F., Senterfitt J.W., Fleishman J.A., Perlman J.F., et al. Variations in the care of HIV-infected adults in the United States. JAMA 281 (1999) 2305-2315
27. Cunningham W.E., Andersen R.M., Katz M.H., Stein M.D., Turner B.J., Crystal S., et al. The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care 37 (1999) 1270-1281
28. Skiest D.J., Rubinstien E., Carley N., Gioiella L., and Lyons R. The importance of comorbidity in HIV-infected patients over 55: A retrospective case-control study. Am J Med 101 (1996) 605-611
29. Manfredi R. HIV disease and advanced age: An increasing therapeutic challenge. Drugs Aging 19 (2002) 647-669
30. CASCADE Collaboration. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naïve individuals and those treated in the monotherapy era. AIDS 18 (2004) 51-58
31. Phillips A.N., Lee C.A., Elford J., Webster A., Janossy G., Timms A., et al. More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. J AIDS 4 (1991) 970-975
32. Hocking J.S., Rodger A.J., Rhodes D.G., and Crofts N. Late presentation of HIV infection associated with prolonged survival following AIDS diagnosis-Characteristics of individuals. Int J STD AIDS 11 (2000) 503-508
33. Castilla J., Sobrino P., de la Fuente L., Noguer I., Guerra L., and Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: Consequences for AIDS incidence. AIDS 16 (2002) 1945-1951
34. Girardi E., Sampaolesi A., Gentile M., Nurra G., and Ippolito G. Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy. J AIDS 25 (2000) 71-76
35. Couturier E., Schwoebel V., Michon C., Jubert J.-B., Delmas M.-C., Morlat P., et al. Determinants of delayed diagnosis of HIV infection in France, 1993-1995. AIDS 12 (1998) 795-800
36. Tyrer F., Walker A.S., Gillett J., and Porter K. The relationship between HIV seroconversion illness, HIV test interval and time to AIDS in a seroconverter cohort. Epidemiol Infect 131 (2003) 1117-1123
37. Stewart S.L., Swallen K.C., Glazer S.L., Horn-Ross P.L., and West D.L. Adjustment of cancer incidence rates for ethnic misclassification. Biometrics 54 (1998) 774-781
38. Swan J., and Edwards B.K. Cancer rates among American Indians and Alaska Natives: Is there a national perspective?. Cancer 98 (2003) 1262-1272
39. Izquierdo J.N., and Schoenbach V.J. The potential and limitations of data from population-based state cancer registries. Am J Public Health 90 (2000) 695-698
40. Centers for Disease Control and Prevention. Advancing HIV prevention: New strategies for a changing epidemic-United States,2003. MMWR Morb Mortal Wkly Rep 52 (2003) 329-332